Key result
Treatment with metformin or lifestyle modification reduces the risk of type 2 diabetes in patients with prediabetes but ultimately provides no mortality benefit.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
While treatment with metformin or lifestyle modification reduces risk for T2D in patients with prediabetes, neither intervention ultimately offers a mortality benefit.
No takes yet. Share an insight, caveat, or question.
Daniel Holligan (2023) studied this question. Treatment with metformin or lifestyle modification reduces the risk of type 2 diabetes in patients with prediabetes but ultimately provides no mortality benefit.
Synapse has enriched 10 related papers. Consider them for comparative context: